NCT03218202 Stricture Definition and Treatment (STRIDENT) Observational Study. Status TERMINATED Phase N/A
NCT03209232 Infliximab Accelerated Induction in Moderate to Severe Pediatric UC Status TERMINATED Phase NA
NCT03196427 Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status COMPLETED Phase PHASE2
NCT03182166 Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization Status COMPLETED Phase PHASE2
NCT03179865 Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis Status COMPLETED Phase N/A
NCT03178669 The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03169894 Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis Status TERMINATED Phase PHASE1
NCT03162432 High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03151850 The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis Status UNKNOWN Phase N/A
NCT03142113 Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis Status COMPLETED Phase N/A
NCT03138655 Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status COMPLETED Phase PHASE2
NCT03124121 Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Status COMPLETED Phase PHASE4
NCT03093259 ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis Status COMPLETED Phase PHASE2